Treatment selection pattern and prognostic factors in older patients with non-small cell lung cancer at recurrence: an observational study

被引:0
|
作者
Sonoda, Dai [1 ]
Maruyama, Raito [1 ]
Kondo, Yasuto [1 ,2 ]
Naito, Masahito [1 ]
Mikubo, Masashi [1 ]
Shiomi, Kazu [1 ]
Satoh, Yukitoshi [1 ,2 ]
机构
[1] Kitasato Univ, Dept Thorac Surg, Sch Med, 1-15-1 Kitasato,Minami Ku, Sagamihara, Kanagawa 2520374, Japan
[2] Kitasato Univ, Dept Thorac Surg, Med Ctr, 6-100 Arai, Kitamoto, Saitama 36408501, Japan
关键词
Lung cancer; Older patients; Performance status; Prognostic factors; Recurrence; Treatment; ELDERLY-PATIENTS; LIFE EXPECTANCY; PHASE-III; OCTOGENARIANS;
D O I
10.1007/s00595-024-02938-3
中图分类号
R61 [外科手术学];
学科分类号
摘要
PurposeSociety is aging, and the proportion of older patients with lung cancer is increasing. However, the treatment choices and prognoses for older patients with cancer recurrence remain unclear. We retrospectively investigated the treatment choices and prognoses of older patients with recurrence.MethodsWe conducted a retrospective review of 1100 patients who underwent complete resection for non-small cell lung cancer at Kitasato University Hospital between 2004 and 2017. Patients of >= 75 years of age were defined as older patients, and the prognosis and prognostic factors of these patients upon recurrence were examined.ResultsAmong the 290 patients who developed recurrence, 106 experienced recurrence at an older age. The factors associated with survival after recurrence included sex, time to recurrence, number of recurrences, performance status at recurrence, and active treatment. As the age at recurrence increased, the proportion of patients who did not receive active treatment increased, as did the proportion for whom the reason was the patient's and family's preferences.ConclusionsA considerable number of older patients who experience recurrence do not wish to receive active treatment. However, the prognosis can be improved by aggressive treatment for recurrence.
引用
收藏
页码:588 / 599
页数:12
相关论文
共 50 条
  • [31] Prognostic Factors in Non-small Cell Lung Cancer Patients with Postoperative Recurrence Following Third-Generation Chemotherapy
    Yamazaki, Koji
    Sugio, Kenji
    Yamanaka, Takeharu
    Hirai, Fumihiko
    Osoegawa, Atsushi
    Tagawa, Tetsuzo
    Fukuyama, Seiichi
    Wataya, Hiroshi
    Seto, Takashi
    Ichinose, Yukito
    ANTICANCER RESEARCH, 2010, 30 (04) : 1311 - 1315
  • [32] Impact of age and comorbidity on treatment of non-small cell lung cancer recurrence following complete resection: A nationally representative cohort study
    Wong, Melisa L.
    McMurry, Timothy L.
    Stukenborg, George J.
    Francescatti, Amanda B.
    Amato-Martz, Carla
    Schumacher, Jessica R.
    Chang, George J.
    Greenberg, Caprice C.
    Winchester, David P.
    McKellar, Daniel P.
    Walter, Louise C.
    Kozower, Benjamin D.
    LUNG CANCER, 2016, 102 : 108 - 117
  • [33] Prognostic Factors in Advanced Non-Small Cell Lung Cancer Patients Treated with Immunotherapy
    Rocco, Danilo
    Della Gravara, Luigi
    Ragone, Angela
    Sapio, Luigi
    Naviglio, Silvio
    Gridelli, Cesare
    CANCERS, 2023, 15 (19)
  • [34] Molecular prognostic factors in resectable non-small cell lung cancer
    Vielh, P
    Spano, JP
    Grenier, J
    Le Chevalier, I
    Soria, JC
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2005, 53 (03) : 193 - 197
  • [35] Prognostic Factors for Brain Metastasis in Non-Small Cell Lung Cancer
    Duma, Narjust
    Sanchez, Laysa
    Miranda, Claudia
    Glisch, Chad
    Abu-Ihweij, Khaleb
    Zhang, Shijia
    Osorio, Carlos
    Listo, Matthew
    Harper, Harry D.
    Gutierrez, Martin
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S535 - S535
  • [36] Risk Factors for Local and Distant Recurrence After Surgical Treatment in Patients With Non-Small-Cell Lung Cancer
    Dziedzic, Dariusz Adam
    Rudzinski, Piotr
    Langfort, Renata
    Orlowski, Tadeusz
    CLINICAL LUNG CANCER, 2016, 17 (05) : E157 - E167
  • [37] Checkpoint inhibitors in older patients with advanced non-small cell lung cancer
    Reale, Maria Lucia
    Romano, Gianpiero Diego
    Paolelli, Loretta
    Leo, Silvana
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2023, 188
  • [38] Stage IV non-small cell lung cancer patients aged 75 years and older
    Tamura, T.
    Kurishima, K.
    Watanabe, H.
    Nakazawa, K.
    Ishikawa, H.
    Satoh, H.
    Hizawa, N.
    EUROPEAN GERIATRIC MEDICINE, 2015, 6 (01) : 31 - 35
  • [39] Prognostic factors in locally advanced non-small cell lung cancer
    Hadidene, Y.
    Kamoun, H.
    Rejeb, H.
    Greb, D.
    Akrout, I.
    Fkih, L.
    Smadhi, H.
    Megdiche, M. L.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [40] Confirmation of a prognostic index for patients with inoperable non-small cell lung cancer
    Wigren, T
    RADIOTHERAPY AND ONCOLOGY, 1997, 44 (01) : 9 - 15